Indian-made HPV vaccine this year
About Cervical Cancer:
- Cervical cancer is a type of cancer that occurs in the cells of the cervix which creates a malignant tumour of the cervix (the lowermost part of the uterus).
- Cervical cancer is curable; however, the possibility of recurrence exits.
- Various strains of the Human papillomavirus (HPV) play a role in causing most cervical cancer.
- 27% of global cervical cancer cases are from India.
- CERVAVAC is a quadrivalent vaccine, making it effective against at least four variants of Human Papilloma Virus (HPV).
- CERVAVAC, developed by Serum Institute of India (SII), was approved by the Drug Controller General of India in July.
- CERVAVAC was developed by SII in partnership with DBT’s Biotechnology Industry Research Assistance Council (BIRAC), and the Bill and Melinda Gates Foundation.
- CERVAVAC is expected to cost ₹200-400 a shot and will be commercially available later this year.
About Human papillomavirus:
- Human papillomavirus (HPV) is a DNA virus from the Papillomaviridae family.
- Human papillomavirus (HPV) is the most common sexually transmitted infection (STI).
- Most people with HPV don’t develop any symptoms but can act as carriers infecting others through sexual contact.
- HPV vaccines can prevent the most common types of infection.
SOURCE: THE HINDU
For more updates Click here